One firm, two conflicting takes on Alnylam’s HELIOS-B 

Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, genetics, government agencies, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. Today, STAT published our annual list of the top books and podcasts to check out this summer. Take a look — we’ve sourced recommendations from Robert Califf, Rochelle Walensky, and also our staff and readers.

Read the rest…

Read Original Article: One firm, two conflicting takes on Alnylam’s HELIOS-B  »

About The Author